AR092772A1 - Derivado de 7-azaindol - Google Patents

Derivado de 7-azaindol

Info

Publication number
AR092772A1
AR092772A1 ARP130103564A ARP130103564A AR092772A1 AR 092772 A1 AR092772 A1 AR 092772A1 AR P130103564 A ARP130103564 A AR P130103564A AR P130103564 A ARP130103564 A AR P130103564A AR 092772 A1 AR092772 A1 AR 092772A1
Authority
AR
Argentina
Prior art keywords
azaindol
derivative
naphthyridin
ylamine
pyrrolo
Prior art date
Application number
ARP130103564A
Other languages
English (en)
Inventor
T Dr Zenke Frank
Dr Jonczyk Alfred
Dr Amendt Christiane
Original Assignee
Merck Patent Ges Mit Beschränkter Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Ges Mit Beschränkter Haftung filed Critical Merck Patent Ges Mit Beschränkter Haftung
Publication of AR092772A1 publication Critical patent/AR092772A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

El compuesto 4-(2-metil-1H-pirrolo[2,3-b]piridin-3-il)-[2,7]naftiridin-1-ilamina de fórmula (1), así como sus sales y/o tautómeros farmacéuticamente aceptables.
ARP130103564A 2012-10-02 2013-10-02 Derivado de 7-azaindol AR092772A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102012019369.6A DE102012019369A1 (de) 2012-10-02 2012-10-02 7-Azaindolderivat

Publications (1)

Publication Number Publication Date
AR092772A1 true AR092772A1 (es) 2015-04-29

Family

ID=49123818

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130103564A AR092772A1 (es) 2012-10-02 2013-10-02 Derivado de 7-azaindol

Country Status (10)

Country Link
US (1) US9382244B2 (es)
EP (1) EP2903992A1 (es)
JP (1) JP2015531381A (es)
CN (1) CN104736543A (es)
AR (1) AR092772A1 (es)
AU (1) AU2013327282A1 (es)
CA (1) CA2886886A1 (es)
DE (1) DE102012019369A1 (es)
IL (1) IL237976A0 (es)
WO (1) WO2014053208A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6836693B2 (ja) 2017-09-28 2021-03-03 シーストーン・ファーマスーティカルズ・（スージョウ）・カンパニー・リミテッドＣｓｔｏｎｅ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ （Ｓｕｚｈｏｕ） Ｃｏ．， Ｌｔｄ． Ａ２ａ受容体アンタゴニストとしての縮合環誘導体
EP3801500A4 (en) * 2018-06-07 2022-03-02 Disarm Therapeutics, Inc. INHIBITORS OF SARM1
BR112021006121A2 (pt) 2018-10-23 2021-07-20 Basf Se compostos, uso dos compostos de fórmula (i), mistura de pesticidas, composições agroquímicas ou veterinárias, métodos para controlar pragas invertebradas e para tratar ou proteger animais e semente
WO2021209265A1 (en) 2020-04-14 2021-10-21 Basf Se Tricyclic pesticidal compounds
CN115944739B (zh) * 2022-12-30 2023-12-19 深圳开悦生命科技有限公司 Rna解旋酶dhx33抑制剂在制备用于治疗黑色素瘤的药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
GB9904387D0 (en) 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
ATE508129T1 (de) 2004-03-30 2011-05-15 Vertex Pharma Als inhibitoren von jak und anderen proteinkinasen geeignete azaindole
US7709645B2 (en) 2004-07-27 2010-05-04 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
JP2008534664A (ja) 2005-04-06 2008-08-28 アストラゼネカ アクチボラグ 置換複素環およびｃｈｋ１、ｐｄｋ１及びｐａｋ阻害剤としてのそれらの使用
WO2007076423A2 (en) 2005-12-22 2007-07-05 Smithkline Beecham Corporation INHIBITORS OF Akt ACTIVITY
CN101541783B (zh) 2006-06-30 2014-10-01 苏尼西斯制药有限公司 吡啶酮基pdk1抑制剂
JP2010514693A (ja) 2006-12-22 2010-05-06 ノバルティス アーゲー Ｐｄｋ１阻害のためのキナゾリン
EP2134346B1 (en) 2007-03-13 2011-09-21 Merck Sharp & Dohme Corp. Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1
WO2008156726A1 (en) 2007-06-20 2008-12-24 Merck & Co., Inc. Inhibitors of janus kinases
AU2008317406B2 (en) 2007-10-25 2013-07-18 Merck Sharp & Dohme Corp. Therapeutic compounds
DE102011009961A1 (de) * 2011-02-01 2012-08-02 Merck Patent Gmbh 7-Azaindolderivate

Also Published As

Publication number Publication date
WO2014053208A1 (de) 2014-04-10
US20150252041A1 (en) 2015-09-10
US9382244B2 (en) 2016-07-05
JP2015531381A (ja) 2015-11-02
DE102012019369A1 (de) 2014-04-03
AU2013327282A1 (en) 2015-05-14
IL237976A0 (en) 2015-05-31
EP2903992A1 (de) 2015-08-12
CN104736543A (zh) 2015-06-24
CA2886886A1 (en) 2014-04-10

Similar Documents

Publication Publication Date Title
PH12016500676A1 (en) Pyrimidine fgfr4 inhibitors
MX2019010446A (es) Compuestos de anillos fusionados biciclicos derivados de piridilo como inhibidores de fgfr4.
CR20140464A (es) Compuestos de heterociclilo
UY35834A (es) Piperazinas de pirazolo sustituido como inhibidores de caseína quinasa 1 delta y epsilon
PH12015502232A1 (en) Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists
TR201904658T4 (tr) Bisiklik füzyonla birleştirilmiş heteroaril veya aril bileşikleri ve bunların ırak4 inhibitörleri olarak kullanımları.
PH12015500064A1 (en) Imidazotriazinecarbonitriles useful as kinase inhibitors
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
RS54492B1 (en) KINASE INHIBITOR REGULATING THE SIGNAL PATH OF APOPTOSIS
UY34264A (es) Compuestos de fórmula genérica 4-(8-metoxi-1-(1-metoxipropan-2-il)-2-(tetrahidro-2H-piran-4-il)-1H- imidazo[4,5-c]quinolin-7-il)-3,5-dimetilisoxazol y sus sales.
UY33883A (es) Novedosos derivados heterocíclicos
MX356341B (es) Agente de control de endoparasitos.
UY34451A (es) Derivados de uracilo como inhibidores de la quinasa axl y c-met
RS54730B1 (sr) Inhibitori beta sekretaze
CR20130539A (es) Triazolopiridinas
EA201591634A1 (ru) Дигидропиридопиримидиновые соединения
MX341456B (es) Amino-quinolinas como inhibidores de cinasa.
PH12015502118A1 (en) Pyridin-4-yl derivatives
EA201491376A1 (ru) Производные 1h-пирроло[2,3-b]пиридина и их применение в качестве ингибиторов киназы
CR20150555A (es) Nuevos derivados de pirrolo[2,3-d]pirimidina
CR20140495A (es) 5-amino[1,4]thiazines como inhibidores de bace1
UY33976A (es) Derivados de pirazolo-pirimidina.
UA113086C2 (xx) Піразольні сполуки як інгібітори sglt1
MX2015013414A (es) N-(2-ciano heterociclil)pirazolo piridonas como inhibidores de janus quinasa.
AR092772A1 (es) Derivado de 7-azaindol

Legal Events

Date Code Title Description
FB Suspension of granting procedure